NeOnc Secures $50M UAE Investment to Advance Brain Cancer Treatments | Nasdaq NTHI
Biotech investors and oncology innovators: NeOnc Technology Holdings (Nasdaq: NTHI) has reached a major milestone by incorporating Neuromina Holdings Limited under the Abu Dhabi Global Market, clearing the path for Quasar Investments’ $50 million cornerstone investment.
📌 Key Highlights:
Partnership accelerates CNS cancer treatment innovation in MENA
Advances development of NEO-212 and NEO-100 therapeutic programs
Executives from NeOnc and Quasar mark the occasion in Dubai
A defining moment for NeOnc’s global growth strategy
This move strengthens NeOnc’s position as a leader in cutting-edge brain cancer therapies worldwide.
🔖 YouTube Tags:
#neonc Technology #NTHI #BrainCancerResearch #CNSCancer #QuasarInvestments #BiotechNews #UAEInvestment #MENAHealthcare #NEO212 #NEO100 #OncologyInnovation #BiotechInvesting #NewsOut #AnaBerry #NasdaqNTHI
